News

Home  >  News > Nostrum BioDiscovery, a new spin-off of the University of Barcelona, the IRB...

Nostrum BioDiscovery, a new spin-off of the University of Barcelona, the IRB Barcelona, the BSC-CNS and the ICREA

A moment during the presentation of the company.

A moment during the presentation of the company.

13/07/2016

Recerca

This morning in Barcelona, the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center - National Supercomputing Center (BSC-CNS) have presented the spin-off Nostrum BioDiscovery, a new biotech company that applies computational simulation to help new drugs and biotech molecules to reach the market. The creation of this spin-off has also been made possible thanks to the Bosch i Gimpera Foundation of the University of Barcelona and the Catalan Institute for Research and Advanced Studies (ICREA).

The creation and launch of the company has been driven by the Botín Foundation, whose technology transfer programme has provided one of the research groups involved support and assessment over five years. Furthermore, the Botín Foundation has invested half a million euros of start-up capital in Nostrum BioDiscovery through its Mind the Gap Programme, which backs early-stage entrepreneurial projects.

Further information.

Share this at:
| More |
  • Follow us:
  • Button to access University of Barcelona's Facebook profile
  • Button to access University of Barcelona's Twitter profile
  • Button to access University of Barcelona's Instagram profile
  • Button to access University of Barcelona's Linkedin profile
  • Button to access University of Barcelona's Youtube profile
  • Button to access University of Barcelona's Google+ profile
  • Button to access University of Barcelona's Flickr profile
Member of International recognition of excellence HR Excellence in Research logo del leru - League of European Research Universities logo del bkc - campus excel·lència logo del health universitat de barcelona campus

© Universitat de Barcelona